FindTrial
Sign In

A randomized study on optimizing clinical outcomes of neonatal peri-cardiopulmoanry bypass period

A randomized study on optimizing clinical outcomes of neonatal peri-cardiopulmonary bypass period

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040230
Enrollment
Unknown
Registered
2020-11-25
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital heart disease

Interventions

1:methylprednisolone
2:methylprdnisolone 15mg/kg twice
3:hydrocortisone 75mg/kg twice
4:none

Sponsors

Fuwai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: Neonates(age<28d),on-pump cardiac surgery, without glucocorticoids therapy

Exclusion criteria

Exclusion criteria: Neonates with cesarean section, dystocia neonates,premature neonates

Design outcomes

Primary

MeasureTime frame
inflammatory factors;—

Countries

China

Contacts

Public ContactJinxiao Hu

Fuwai Hospital, CAMS & PUMC

donnajin@163.com+86 13121463057

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026